# Comparison Trial of OPA-15406 Ointment in Adult Patients With Atopic DermatitisSyndrome

> **NCT03908970** · PHASE3 · COMPLETED · sponsor: **Otsuka Pharmaceutical Co., Ltd.** · enrollment: 364 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** 1% OPA-15406
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03908970
- **Lead sponsor:** Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-25
- **Primary completion:** 2019-12-28
- **Final completion:** 2019-12-28
- **Target enrollment:** 364 (ACTUAL)
- **Last updated:** 2021-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03908970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03908970, "Comparison Trial of OPA-15406 Ointment in Adult Patients With Atopic DermatitisSyndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03908970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*